Latest News


Cancer

Crucial funds strengthening our research expertise.

A group of researchers will have the chance to broaden their skills and establish new collaborations following a funding boost from the Royal North Shore Hospital Scientific Staff Council. The council has awarded 12 travel grants to scientists working within the district and the Kolling Institute. The diverse group of leaders is driving research progress into heart and kidney disease, cancer, muscu.....
Read more

Category: Funding support, Research Excellence

Technology giving our researchers the edge.

Impressive new infrastructure at the Kolling Institute is set to drive progress with our research into cancer and neuroscience. The equipment includes a digital spatial profiling system, which is regarded as one of the most exciting technological advances globally in the investigation of tissues. The $525,000 instrument has been made possible following a LIEF grant through the Australian Research C.....
Read more

Category: Funding support

Act of generosity continues to deliver hope for those with cancer.

The Kolling Institute hosted a special visit by the family of the late Bill Walsh who donated vital funds to establish a cancer laboratory within the Kolling. His family, including his wife, daughters and grandchildren visited the lab to maintain their strong ties with the research team and meet with Academic Director Professor Jim Elliott. Established in 1980, the Bill Walsh Cancer Research Labora.....
Read more

Category: Funding support, Research Excellence

New approach revolutionising ovarian cancer research.

With ovarian cancer continuing to have a devastating outcome for many women, new research at the Kolling Institute is offering hope. The disease has the lowest survival rate of any women’s cancer, with only 48 per cent of women living beyond five years after diagnosis. Ovarian cancer is often diagnosed late because the symptoms are vague, like bloating, nausea, indigestion, excessive tiredness, and.....
Read more

Category: New Treatment, Research Excellence

Recognition of our impact on the world stage.

Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than a dozen researchers from the Kolling have been profiled in an international study recognising the world’s best. Published by Stanford University, the study has identified the top two per cent of researchers in the world across individual fields. The study is based on metrics from Scopus, a database o.....
Read more

Category: Research Excellence

Philanthropic funds creating travel opportunities  .

A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust. Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills. It’s anticipated the travel program will not.....
Read more

Category: Awards, Research Excellence

Kolling awards unveiled.

We are pleased to announce the successful recipients of our annual Kolling Institute awards program. Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling. The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well as overall a.....
Read more

Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research

Researchers to join leading cancer care centres in exciting new trial.

Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project investigating a revolutionary approach to care for those with neuroendocrine tumours. Cancer specialists Professor Nick Pavlakis and Dr David Chan will join the AUS-NET trial after a funding announcement by Health Minister Greg Hunt. The study will assess whether a new patient-specific care model imp.....
Read more

Category: Funding support, Research Excellence

Exciting study to investigate new treatment for acute myeloid leukaemia.

The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to examine a revolutionary approach to treatment for those with acute myeloid leukaemia. This aggressive form of blood cancer has a tragically poor survival rate, and while we have seen tremendous progress for many other types of cancer in recent years, there have been very limited improvements in treat.....
Read more

Category: Funding support, Research Excellence

New cutting-edge technology coming to the Kolling.

The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities. The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 contribution, .....
Read more

Category: Research Excellence, World-leading technology